MAIA Biotechnology Inc. (NYSE American: MAIA) announced it has dosed the first patient in Taiwan for the expansion phase of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE